<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:chebi fb="17" ids="39025">HDL</z:chebi> molecules have an established role in the regression processes of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> as well as a putative role as <z:chebi fb="1" ids="35472">antiinflammatory agents</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Our study investigated whether <z:e sem="disease" ids="C1704429" disease_type="Disease or Syndrome" abbrv="FHA|HDLC|HDLD">familial hypoalphalipoproteinemia</z:e>, a genetic form of <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> characterized by very low <z:chebi fb="17" ids="39025">HDL</z:chebi> levels, might be associated with increased <z:mp ids='MP_0001845'>inflammation</z:mp> markers such as C-reactive protein </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS AND RESULTS: A total of 50 subjects with <z:e sem="disease" ids="C0473527" disease_type="Disease or Syndrome" abbrv="">hypoalphalipoproteinemia</z:e> (age, 53.1+/-16.7 years) were compared with 64 healthy controls (age, 51.9+/-12.4 years) </plain></SENT>
<SENT sid="3" pm="."><plain>Apart from significantly lower values of <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> (30.2+/-4.0 versus 52.5+/-12.7 mg/dL, P&lt;0.0001) and <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> AI (113.3+/-20.0 versus 155.4+/-24.9 mg/dL, P&lt;0.0001) and higher levels of <z:chebi fb="4" ids="17855">triglycerides</z:chebi> (141.3+/-62.9 versus 73.5+/-39.9 mg/dL, P&lt;0.0001), patients did not show different plasma values of total cholesterol and <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi> when compared with healthy controls (181.5+/-36.6 versus 186.3+/-32.6 mg/dL; 123.0+/-31.5 versus 119.1+/-30.3 mg/dL) </plain></SENT>
<SENT sid="4" pm="."><plain>CRP plasma values were significantly higher in patients than in controls (median 0.34 [range 0.02 to 4.66] versus 0.07 [0.02 to 0.85] mg/dL, P&lt;0.0001) </plain></SENT>
<SENT sid="5" pm="."><plain>In the patient group, CRP values were significantly higher in subjects with angiographically documented coronary atherosclerotic disease than in those without </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, CRP concentrations were inversely correlated with both <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> (r= -0.44, P=0.0006) and <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> AI (r= -0.45, P=0.0006) values </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Elevation of C-reactive protein values in <z:e sem="disease" ids="C1704429" disease_type="Disease or Syndrome" abbrv="FHA|HDLC|HDLD">familial hypoalphalipoproteinemia</z:e>, in the absence of signs and symptoms of local or systemic <z:mp ids='MP_0001845'>inflammation</z:mp> or systemic or <z:e sem="disease" ids="C0277556" disease_type="Disease or Syndrome" abbrv="">recurrent disease</z:e>, may suggest an upregulation of proinflammatory mechanisms, which is further exacerbated by the presence of coronary atherosclerotic disease </plain></SENT>
</text></document>